NCT05145166View on ClinicalTrials.gov

Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old

CompletedOBSERVATIONAL

Enrollment

10,000

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

November 6, 2020

Study Completion Date

March 25, 2021

Conditions

Mumps

Interventions

BIOLOGICAL

Safety group

All of the participants(N=10000) received one dose of live attenuated mumps vaccine.Vaccine will given by single intramuscular injection(0.5 ml) on day 0.

Trial Locations (3)

712000

Xianyang Center for Disease Control and Prevention, Xianyang

716000

Yanan Center for Disease Prevention and Control, Yan’an

721006

Baoji Center for Disease Prevention and Control, Baoji

All Listed Sponsors

lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY

NCT05145166 - Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old | Biotech Hunter | Biotech Hunter